文献速递主动脉疾病

实施涉及主动脉弓的B型主动脉夹层治疗策略后的主动脉结局

Aortic Outcome after Implementation of a Treatment Strategy for Type B Aortic Dissection Involving the Aortic Arch.
PubMed 文献 · Ann Vasc Surg · 2024-08-09

本回顾性观察研究纳入2016年1月至2022年12月本机构治疗的22例非A非B型急性主动脉夹层(B 1-2 D)患者,分析药物与手术治疗的死亡、再干预及重塑结局。结果显示手术组假腔血栓化率100% vs 药物组55.5%(P=0.033),第3和第4区主动脉重塑更优。

要点

  • 非A非B型急性主动脉夹层占急性主动脉综合征的4.2%(22/519)。
  • 手术组假腔血栓化率100% vs 药物组55.5%(P=0.033)。
  • 手术组第3区(P<0.001)和第4区(P=0.038)主动脉重塑显著优于药物组。

核心结论

  • 非A非B型急性主动脉夹层的最佳治疗尚未确立。
  • 作者主张在急性夹层后期间先药物稳定,对适合者采用开放手术,以促进主动脉重塑,且在常规开展冰冻象鼻(FET)的中心风险可接受。

研究设计与样本

  • 回顾性观察研究,遵循STROBE清单。
  • 回顾2016年1月至2022年12月本机构治疗的所有非A非B型急性主动脉夹层(B 1-2 D)病例,共22例(占519例急性主动脉综合征的4.2%),其中男性16例(72.7%),平均年龄61.5岁±14.7。

主要发现

  • 11例仅接受最佳药物治疗(BMT),其中1例(9.1%)在诊断后2天因主动脉破裂猝死。
  • 其余11例接受冰冻象鼻(FET)手术:7例(31.8%)因濒临主动脉破裂或逆行主动脉夹层扩展风险急诊手术,4例(26.7%)在初次就诊后1个月内延期手术。
  • FET和BMT的总体院内死亡率均为9.1%。
  • 中位随访40个月(范围2天至200个月)期间无其他死亡。
  • 手术组与药物组相比,假腔血栓化率100% vs 55.5%(P=0.033),第3区(P<0.001)和第4区(P=0.038)主动脉重塑显著更优。

临床怎么用

  • 作者主张在急性夹层后期间先药物稳定,对适合者采用开放手术,以促进主动脉重塑,且在常规开展FET的中心风险可接受。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the outcomes achieved after implementing a treatment strategy for non-A non-B (NANB) (B 1-2 D according to the latest consensus document of the Society of Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) acute aortic dissection (AAD)). METHODS: This retrospective observational study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist. All cases of NANB AAD (B 1-2 D) treated at our institution between January 2016 and December 2022 were reviewed. Morbidity, mortality, aortic-related reintervention, and remodeling were analyzed. RESULTS: Among 519 cases of acute aortic syndrome, n = 22 (4.2%) patients presented with NANB AAD (B 1-2 D) (n = 16,72.7% men, mean age 61.5 years+/14.7). Eleven cases were managed with best medical treatment (BMT) alone. Among them, one patient (9.1%) died suddenly 2 days after diagnosis for aortic rupture. Frozen elephant trunk procedure (FET) was required in the remaining 11 patients: 7 (31.8%) needed emergent operation for risks of impending aortic rupture or retrograde aortic dissection extension, and 4 (26.7%) underwent delayed surgery within a month from initial presentation. Overall, in-hospital mortality was 9.1% with both FET and BMT. At a median follow-up of 40 months (range 2 days-200 months) no other deaths occurred. A statistically significant differences in the rate of false lumen thrombosis (100% vs 55.5%, P = 0.033), and a significant positive aortic remodeling in zone 3 (P < 0.001) and 4 (P = 0.038) were reported in operated versus medically managed patients. CONCLUSIONS: The best treatment for NANB is not established. We advocate for medical stabilization with an operative approach that favors open surgery in the acute post dissection period, promotes aortic remodeling, and carries acceptable risk in centers where FET is performed routinely.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Borghese O, Pisani A, Lopez-Marco A, et al. Aortic Outcome after Implementation of a Treatment Strategy for Type B Aortic Dissection Involving the Aortic Arch. Ann Vasc Surg. 2024. PMID: 39127369. doi:10.1016/j.avsg.2024.07.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。